Diridavumab

A4DAB087 | Phase-II
Influenza A HA2
G1 / None
National Institute of Allergy and Infectious Diseases Crucell
Phase-II
Whole mAb
CR-6261 CR6261 JNJ-54235025 JNJ54235025 mAb CR6261 mAb-CR6261
—
Avg A4D Score
-0.5563
Score Range
-0.67 to -0.44
Structures
25
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB087_4evn_E_F 4evn 96% -0.6583 6.0 9.0 -0.0138 -0.7479
A4DAB087_8f38_F_I 8f38 100% -0.4631 6.5 9.0 -0.1837 -0.5483
A4DAB087_3gbn_H_L 3gbn 100% -0.4413 6.0 9.0 -0.1548 -0.5001
A4DAB087_4evn_O_P 4evn 96% -0.6327 6.0 9.0 -0.0274 -0.7169
A4DAB087_8f38_D_G 8f38 100% -0.4749 6.5 9.0 -0.1688 -0.5681
A4DAB087_8dim_B_C 8dim 100% -0.4797 6.0 9.0 -0.231 -0.5555
A4DAB087_8diu_H_I 8diu 100% -0.4947 6.0 9.0 -0.2492 -0.5691
A4DAB087_5c0s_H_L 5c0s 100% -0.6569 6.0 9.0 -0.2265 -0.7169
A4DAB087_4evn_M_N 4evn 96% -0.6568 6.0 9.0 -0.0383 -0.7429
A4DAB087_8f38_E_H 8f38 100% -0.4849 6.0 9.0 -0.2095 -0.5688
A4DAB087_3gbm_H_L 3gbm 100% -0.6623 6.0 9.0 -0.3956 -0.7325
A4DAB087_4evn_C_D 4evn 96% -0.6584 6.0 9.0 -0.0188 -0.7473
A4DAB087_8dis_H_L 8dis 100% -0.5174 6.5 9.0 -0.2289 -0.6048
A4DAB087_6uyn_H_L 6uyn 100% -0.4895 6.5 9.0 -0.2697 -0.5373
A4DAB087_8diu_G_C 8diu 100% -0.5247 6.0 9.0 -0.2843 -0.5975
A4DAB087_8dim_H_I 8dim 100% -0.4766 6.0 9.0 -0.2274 -0.5525
A4DAB087_4evn_I_J 4evn 96% -0.6426 6.0 9.0 -0.0367 -0.7269
A4DAB087_8dis_B_G 8dis 100% -0.491 6.0 9.0 -0.1981 -0.5797
A4DAB087_4evn_K_L 4evn 96% -0.6534 6.0 9.0 0.0068 -0.7453
A4DAB087_4evn_A_B 4evn 96% -0.6684 6.0 9.0 -0.0104 -0.7599
A4DAB087_3gbm_I_M 3gbm 100% -0.592 6.0 9.0 -0.2694 -0.6777
A4DAB087_8dis_A_C 8dis 100% -0.4818 6.0 9.0 -0.0908 -0.6002
A4DAB087_4evn_G_H 4evn 96% -0.6569 6.0 9.0 -0.0033 -0.7478
A4DAB087_8dim_E_F 8dim 100% -0.457 6.0 9.0 -0.1436 -0.5525
A4DAB087_8diu_E_F 8diu 100% -0.491 6.5 9.0 -0.2662 -0.559